Eli Lilly and Company <LLY.N>: Wells Fargo raises target price to $1330 from $1280
LLY•Related News
Rallybio swings to Q2 net income of $43.67 million; operating loss narrows to $5.65 million
RLYB•
Establishment Labs Q2 FY26 net loss narrows to $11.7 million; revenue rises 31.7% to $67.5 million
ESTA•
Annexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients
ANNX•
E.L.F. Beauty, Inc. <ELF.N>: Bernstein raises target price to $121 from $113
ELF•
Tejon Ranch Q2 FY26 swings to net profit of $2.6 million; revenue rises 56.76% to $17.4 million
TRC•